Caisse DE Depot ET Placement DU Quebec lowered its stake in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 54.8% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 215,874 shares of the company's stock after selling 262,037 shares during the quarter. Caisse DE Depot ET Placement DU Quebec owned 0.09% of Cardinal Health worth $25,531,000 as of its most recent filing with the SEC.
A number of other hedge funds have also made changes to their positions in the company. Rothschild Investment LLC boosted its stake in shares of Cardinal Health by 10.1% in the fourth quarter. Rothschild Investment LLC now owns 858 shares of the company's stock valued at $101,000 after purchasing an additional 79 shares during the period. Private Trust Co. NA increased its stake in shares of Cardinal Health by 11.0% during the fourth quarter. Private Trust Co. NA now owns 930 shares of the company's stock worth $110,000 after buying an additional 92 shares during the period. Checchi Capital Advisers LLC raised its holdings in Cardinal Health by 2.7% in the fourth quarter. Checchi Capital Advisers LLC now owns 3,479 shares of the company's stock valued at $411,000 after acquiring an additional 93 shares in the last quarter. TIAA Trust National Association grew its holdings in Cardinal Health by 4.5% during the 4th quarter. TIAA Trust National Association now owns 2,183 shares of the company's stock worth $258,000 after acquiring an additional 94 shares in the last quarter. Finally, MWA Asset Management increased its position in shares of Cardinal Health by 2.9% in the 4th quarter. MWA Asset Management now owns 3,324 shares of the company's stock valued at $393,000 after purchasing an additional 95 shares during the last quarter. Institutional investors and hedge funds own 87.17% of the company's stock.
Analyst Upgrades and Downgrades
Several equities analysts recently commented on CAH shares. Jefferies Financial Group raised Cardinal Health from a "hold" rating to a "buy" rating and increased their target price for the company from $140.00 to $150.00 in a report on Wednesday, February 5th. UBS Group boosted their target price on Cardinal Health from $150.00 to $160.00 and gave the company a "buy" rating in a report on Tuesday, April 29th. Citigroup reaffirmed a "neutral" rating on shares of Cardinal Health in a research report on Thursday. JPMorgan Chase & Co. lifted their target price on shares of Cardinal Health from $142.00 to $145.00 and gave the company a "neutral" rating in a report on Tuesday, February 4th. Finally, Mizuho increased their price target on Cardinal Health from $142.00 to $150.00 and gave the stock an "outperform" rating in a report on Monday, March 31st. Four equities research analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $146.43.
Check Out Our Latest Stock Analysis on CAH
Cardinal Health Trading Down 0.1 %
Shares of CAH traded down $0.19 during mid-day trading on Tuesday, reaching $151.80. The company had a trading volume of 2,056,713 shares, compared to its average volume of 2,196,065. The stock has a market cap of $36.23 billion, a price-to-earnings ratio of 28.32, a price-to-earnings-growth ratio of 1.49 and a beta of 0.66. The firm has a fifty day simple moving average of $132.87 and a 200-day simple moving average of $125.44. Cardinal Health, Inc. has a fifty-two week low of $93.17 and a fifty-two week high of $154.10.
Cardinal Health (NYSE:CAH - Get Free Report) last released its quarterly earnings data on Thursday, May 1st. The company reported $2.35 earnings per share for the quarter, beating the consensus estimate of $2.15 by $0.20. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. The business had revenue of $54.88 billion for the quarter, compared to analyst estimates of $55.33 billion. During the same period in the previous year, the company posted $2.08 EPS. The company's revenue was up .0% compared to the same quarter last year. As a group, equities analysts predict that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.
Cardinal Health Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Tuesday, July 15th. Stockholders of record on Tuesday, July 1st will be given a $0.5107 dividend. This is an increase from Cardinal Health's previous quarterly dividend of $0.51. The ex-dividend date is Tuesday, July 1st. This represents a $2.04 annualized dividend and a dividend yield of 1.35%. Cardinal Health's dividend payout ratio is presently 31.51%.
About Cardinal Health
(
Free Report)
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
See Also

Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.